BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20450430)

  • 21. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application.
    Saggiorato E; De Pompa R; Volante M; Cappia S; Arecco F; Dei Tos AP; Orlandi F; Papotti M
    Endocr Relat Cancer; 2005 Jun; 12(2):305-17. PubMed ID: 15947105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of TROP-2 expression in papillary thyroid carcinoma and comparison with HBME-1, galectin-3 and cytokeratin 19.
    Murtezaoglu AR; Gucer H
    Pol J Pathol; 2017; 68(1):1-10. PubMed ID: 28547974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of the cytological diagnostic accuracy of follicular thyroid lesions by the use of the Ki-67 proliferative index in addition to cytokeratin-19 and HBME-1 immunomarkers: a study of 61 cases of liquid-based FNA cytology with histological controls.
    Lacoste-Collin L; d'Aure D; Bérard E; Rouquette I; Delisle MB; Courtade-Saïdi M
    Cytopathology; 2014 Jun; 25(3):160-9. PubMed ID: 24460983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Universal markers of thyroid malignancies: galectin-3, HBME-1, and cytokeratin-19.
    Barut F; Onak Kandemir N; Bektas S; Bahadir B; Keser S; Ozdamar SO
    Endocr Pathol; 2010 Jun; 21(2):80-9. PubMed ID: 20198455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galectin-3 and HBME-1 Expression on Agarose Cell Blocks from Fine-needle aspirates of Follicular Cell-derived Thyroid Tumors.
    Abu-Sinna E; Hasan MY; El-Deftar MM; Amer SA; Abdelsalam LO; Nakhla JA
    J Cytol; 2018; 35(1):27-32. PubMed ID: 29403166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV.
    de Micco C; Savchenko V; Giorgi R; Sebag F; Henry JF
    Br J Cancer; 2008 Feb; 98(4):818-23. PubMed ID: 18212751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
    Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
    Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid.
    Rossi ED; Raffaelli M; Mule' A; Miraglia A; Lombardi CP; Vecchio FM; Fadda G
    Histopathology; 2006 Jun; 48(7):795-800. PubMed ID: 16722927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions.
    Kim MJ; Kim HJ; Hong SJ; Shong YK; Gong G
    Acta Cytol; 2006; 50(1):28-34. PubMed ID: 16514837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of chemokine CXC motif ligand 12 as a novel diagnostic marker in preoperative fine-needle aspiration biopsy for papillary thyroid carcinoma.
    Jung YY; Park IA; Kim MA; Min HS; Won JK; Ryu HS
    Acta Cytol; 2013; 57(5):447-54. PubMed ID: 24021782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
    J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of immunocytochemical stainings for galectin-3, CD44, and HBME1 to fine-needle aspiration cytology diagnosis of papillary thyroid carcinoma.
    Das DK; Al-Waheeb SK; George SS; Haji BI; Mallik MK
    Diagn Cytopathol; 2014 Jun; 42(6):498-505. PubMed ID: 24273003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma.
    Sapio MR; Guerra A; Posca D; Limone PP; Deandrea M; Motta M; Troncone G; Caleo A; Vallefuoco P; Rossi G; Fenzi G; Vitale M
    Endocr Relat Cancer; 2007 Dec; 14(4):1089-97. PubMed ID: 18045960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions.
    Oestreicher-Kedem Y; Halpern M; Roizman P; Hardy B; Sulkes J; Feinmesser R; Stern Y
    Head Neck; 2004 Nov; 26(11):960-6. PubMed ID: 15386597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology.
    Fadda G; Rossi ED; Raffaelli M; Pontecorvi A; Sioletic S; Morassi F; Lombardi CP; Zannoni GF; Rindi G
    Eur J Endocrinol; 2011 Sep; 165(3):447-53. PubMed ID: 21724837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HBME-1 and CD15 immunocytochemistry in the follicular variant of thyroid papillary carcinoma.
    Ohta M; Ookoshi T; Naiki H; Imamura Y
    Pathol Int; 2015 Mar; 65(3):119-25. PubMed ID: 25597783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical Expression of HBME-1 and TROP-2 in Some Follicular-Derived Thyroid Lesions.
    Abu-Seadah SS; Attiah SM; Ali MY; Shams El-Din M; El-Kholy MA
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2305-2311. PubMed ID: 37505760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1].
    Tang QS; Teng XD; Ding W; Zhou J; Yao HT; Ying LX; Xu LM
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):745-8. PubMed ID: 22336157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical thyroid nodules express both HBME-1 and Galectin-3, two phenotypic markers of papillary thyroid carcinoma.
    Coli A; Bigotti G; Parente P; Federico F; Castri F; Massi G
    J Exp Clin Cancer Res; 2007 Jun; 26(2):221-7. PubMed ID: 17725102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Galectin-3 and HBME-1 improve the accuracy of core biopsy in indeterminate thyroid nodules.
    Trimboli P; Guidobaldi L; Amendola S; Nasrollah N; Romanelli F; Attanasio D; Ramacciato G; Saggiorato E; Valabrega S; Crescenzi A
    Endocrine; 2016 Apr; 52(1):39-45. PubMed ID: 26142180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.